IP Library Assignment 037942/0611
Patent Assignment
Reel/Frame 037942/0611

Assignment of Assignor's Interest

Recorded: 2016-03-10 Pages: 12
Assignors
BOURNE, GREGORY THOMAS
Executed: 2016-03-03
BHANDARI, ASHOK
Executed: 2016-03-07
CHENG, XIAOLI
Executed: 2016-03-09
FREDERICK, BRIAN TROY
Executed: 2016-03-09
ZHANG, JIE
Executed: 2016-03-03
PATEL, DINESH V.
Executed: 2016-03-08
LIU, DAVID
Executed: 2016-03-08
Assignee
PROTAGONIST THERAPEUTICS, INC.
521 COTTONWOOD DRIVE, SUITE A, MILPITAS, CALIFORNIA, 95035
Covered Properties (3)
Oral Peptide Inhibitors of Interleukin-23 Receptor and Their Use to Treat Inflammatory Bowel Diseases
Application: 62/025,899 →
Oral Peptide Inhibitors of Interleukin-23 Receptor and Their Use to Treat Inflammatory Bowel Diseases
Application: 62/119,688 →
Oral Peptide Inhibitors of Interleukin-23 Receptor and Their Use to Treat Inflammatory Bowel Diseases
Patent: 9,624,268 →
Application: 14/800,627 →
Publication: US 2016/0145306
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 15, 2015
From: BOURNE, GREGORY; BHANDARI, ASHOK; CHENG, XIAOLI; FREDERICK, BRIAN TROY
To: PROTAGONIST THERAPEUTICS, INC.
Reel/Frame 036105/0725 →
Assignment of Assignor's Interest Jul 15, 2015
From: BHANDARI, ASHOK; BOURNE, GREGORY; CHENG, XIAOLI; FREDERICK, BRIAN TROY
To: PROTAGONIST THERAPEUTICS, INC.
Reel/Frame 036105/0732 →